Treatment with Soluble Activin Receptor Type IIB Alters Metabolic Response in Chemotherapy-Induced Cachexia.

Cancers (Basel) · 2019 · PMC6770556 · PMID 31438622

Europe PMC DOI

hedged sentence

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

did not reach statistical significancep = 0.08so close (0.05 < p ≤ 0.1)

For the C3.1 and C3-DC/C4-OH species, co-treatment lead to significantly higher levels than with Folfiri treatment alone, while for C2 and C5-OH/C3-DC.M, there was a trend toward decreasing levels that did not reach statistical significance ( p = 0.08 and 0.09, respectively).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.